Should You Buy Pfizer For 25% Gains?
- Friday, May 7, 2021, 7:10
- Market
- Add a comment
This strong performance can be attributed to a very high demand for Pfizer’s Covid-19 vaccine, which garnered $3.5 billion in Q1 sales. While the company also revised its full-year 2021 EPS guidance upward to $3.55 to $3.65, we expect this figure to very conservative going by the expected rise in…
About the Author
admin123 has written 23527 stories on this site.
